Relmada Therapeutics (RLMD) Preferred Shares (2014 - 2015)
Relmada Therapeutics' (RLMD) quarterly Preferred Shares came in at $72.0 in Q3 2015, down 97.84% year-on-year from $3337.0 in Q3 2014, and little changed on a QoQ basis from $72.0 in Q2 2015.
Relmada Therapeutics (RLMD) Preferred Shares (2014 - 2015) Analysis & Trends
Relmada Therapeutics (RLMD) has 2 years of Preferred Shares data on file, last reported at $72.0 in Q3 2015.
- On a quarterly basis, Preferred Shares fell 97.84% year-over-year to $72.0 in Q3 2015; TTM through Sep 2015 was $72.0, a 97.84% decrease from a year earlier, with the FY2015 full-year figure at $72.0, down 89.21% from the prior year.
- Preferred Shares for Q3 2015 stood at $72.0, roughly flat from $72.0 in the prior quarter.
- Over the last five years, Preferred Shares for RLMD reached as high as $3337.0 in Q3 2014 and fell as low as $72.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 72.00 |
| Jun 30, 2015 | 72.00 |
| Mar 31, 2015 | 465.00 |
| Dec 31, 2014 | 465.00 |
| Sep 30, 2014 | 3,337.00 |
| Jun 30, 2014 | 667.00 |